Elevance Health Price to Sales Ratio 2010-2024 | ELV
Historical PS ratio values for Elevance Health (ELV) over the last 10 years. The current P/S ratio for Elevance Health as of June 27, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Elevance Health P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-06-27 | 535.77 | 0.74 | |
| 2024-03-31 | 516.97 | $726.22 | 0.71 |
| 2023-12-31 | 468.61 | $720.35 | 0.65 |
| 2023-09-30 | 431.37 | $705.16 | 0.61 |
| 2023-06-30 | 438.72 | $688.89 | 0.64 |
| 2023-03-31 | 452.60 | $664.01 | 0.68 |
| 2022-12-31 | 503.31 | $643.94 | 0.78 |
| 2022-09-30 | 444.60 | $627.71 | 0.71 |
| 2022-06-30 | 471.11 | $608.43 | 0.77 |
| 2022-03-31 | 478.28 | $586.54 | 0.82 |
| 2021-12-31 | 450.09 | $561.15 | 0.80 |
| 2021-09-30 | 360.97 | $538.07 | 0.67 |
| 2021-06-30 | 368.56 | $515.02 | 0.72 |
| 2021-03-31 | 345.49 | $492.78 | 0.70 |
| 2020-12-31 | 308.01 | $477.82 | 0.64 |
| 2020-09-30 | 256.89 | $457.97 | 0.56 |
| 2020-06-30 | 250.63 | $437.99 | 0.57 |
| 2020-03-31 | 215.68 | $420.98 | 0.51 |
| 2019-12-31 | 285.91 | $399.49 | 0.72 |
| 2019-09-30 | 226.65 | $382.67 | 0.59 |
| 2019-06-30 | 265.56 | $367.68 | 0.72 |
| 2019-03-31 | 269.27 | $356.86 | 0.75 |
| 2018-12-31 | 245.78 | $348.58 | 0.71 |
| 2018-09-30 | 256.46 | $344.80 | 0.74 |
| 2018-06-30 | 222.14 | $341.19 | 0.65 |
| 2018-03-31 | 204.37 | $337.19 | 0.61 |
| 2017-12-31 | 208.62 | $334.74 | 0.62 |
| 2017-09-30 | 175.51 | $331.04 | 0.53 |
| 2017-06-30 | 173.26 | $326.88 | 0.53 |
| 2017-03-31 | 151.78 | $324.14 | 0.47 |
| 2016-12-31 | 131.43 | $316.67 | 0.42 |
| 2016-09-30 | 114.05 | $309.66 | 0.37 |
| 2016-06-30 | 118.92 | $303.75 | 0.39 |
| 2016-03-31 | 125.24 | $296.72 | 0.42 |
| 2015-12-31 | 125.03 | $288.82 | 0.43 |
| 2015-09-30 | 124.95 | $281.24 | 0.44 |
| 2015-06-30 | 145.87 | $272.63 | 0.54 |
| 2015-03-31 | 136.69 | $264.26 | 0.52 |
| 2014-12-31 | 110.78 | $257.35 | 0.43 |
| 2014-09-30 | 105.09 | $249.87 | 0.42 |
| 2014-06-30 | 94.19 | $243.19 | 0.39 |
| 2014-03-31 | 86.77 | $236.95 | 0.37 |
| 2013-12-31 | 80.15 | $233.37 | 0.34 |
| 2013-09-30 | 72.23 | $221.61 | 0.33 |
| 2013-06-30 | 70.40 | $210.67 | 0.33 |
| 2013-03-31 | 56.69 | $198.84 | 0.29 |
| 2012-12-31 | 51.84 | $186.86 | 0.28 |
| 2012-09-30 | 49.11 | $181.64 | 0.27 |
| 2012-06-30 | 53.74 | $176.67 | 0.30 |
| 2012-03-31 | 61.91 | $170.80 | 0.36 |
| 2011-12-31 | 55.33 | $164.60 | 0.34 |
| 2011-09-30 | 54.32 | $157.81 | 0.34 |
| 2011-06-30 | 65.29 | $151.31 | 0.43 |
| 2011-03-31 | 57.66 | $144.88 | 0.40 |
| 2010-12-31 | 46.80 | $139.36 | 0.34 |
| 2010-09-30 | 46.62 | $143.65 | 0.32 |
| 2010-06-30 | 40.28 | $139.77 | 0.29 |
| 2010-03-31 | 52.99 | $137.25 | 0.39 |
| 2009-12-31 | 47.98 | $133.90 | 0.36 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $124.523B | $171.340B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora (COR) | United States | $45.467B | 17.73 |
| ICON (ICLR) | Ireland | $25.839B | 24.39 |
| DiDi Global (DIDIY) | China | $20.560B | 0.00 |
| Avantor (AVTR) | United States | $14.550B | 21.42 |
| CochLear (CHEOY) | Australia | $14.235B | 0.00 |
| Natera (NTRA) | United States | $13.510B | 0.00 |
| Medpace Holdings (MEDP) | United States | $13.148B | 43.26 |
| Revvity (RVTY) | United States | $13.044B | 22.88 |
| Viatris (VTRS) | United States | $12.478B | 3.73 |
| Charles River Laboratories (CRL) | United States | $10.681B | 20.45 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.978B | 0.00 |
| Solventum (SOLV) | United States | $8.865B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.503B | 0.00 |
| HealthEquity (HQY) | United States | $7.335B | 47.10 |
| Organon (OGN) | United States | $5.295B | 5.02 |
| Bausch + Lomb (BLCO) | Canada | $5.197B | 20.80 |
| Doximity (DOCS) | United States | $5.160B | 36.14 |
| PACS (PACS) | United States | $4.601B | 0.00 |
| Life Times (LTH) | United States | $3.772B | 39.52 |
| Sotera Health (SHC) | United States | $3.369B | 16.53 |
| Surgery Partners (SGRY) | United States | $3.091B | 28.28 |
| GoodRx Holdings (GDRX) | United States | $2.885B | 109.86 |
| Progyny (PGNY) | United States | $2.725B | 46.92 |
| Agilon Health (AGL) | United States | $2.710B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.968B | 7.80 |
| Premier (PINC) | United States | $1.926B | 8.24 |
| NovoCure (NVCR) | Jersey | $1.897B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.854B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.720B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.501B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.207B | 0.00 | |
| CareDx (CDNA) | United States | $0.749B | 0.00 |
| Embecta (EMBC) | United States | $0.719B | 4.89 |
| InnovAge Holding (INNV) | United States | $0.713B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.696B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.608B | 6.45 |
| Auna S.A (AUNA) | Luxembourg | $0.594B | 0.00 |
| Sharecare (SHCR) | United States | $0.500B | 0.00 |
| Enhabit (EHAB) | United States | $0.430B | 42.85 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.410B | 0.00 |
| ModivCare (MODV) | United States | $0.359B | 6.71 |
| QDM (QDMI) | Hong Kong, SAR China | $0.353B | 9.24 |
| Sonida Senior Living (SNDA) | United States | $0.348B | 0.00 |
| DocGo (DCGO) | United States | $0.326B | 17.83 |
| LifeMD (LFMD) | United States | $0.279B | 0.00 |
| MultiPlan (MPLN) | United States | $0.272B | 0.00 |
| Beauty Health (SKIN) | United States | $0.235B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.208B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.187B | 0.00 |
| Biodesix (BDSX) | United States | $0.172B | 0.00 |
| So-Young (SY) | China | $0.108B | 52.00 |
| Pono Capital Two (PTWO) | United States | $0.070B | 0.00 |
| NeueHealth (NEUE) | United States | $0.043B | 5.78 |
| Co-Diagnostics (CODX) | United States | $0.040B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.034B | 0.00 |
| Oncology Institute (TOI) | United States | $0.033B | 0.00 |
| Nutex Health (NUTX) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.021B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.021B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.019B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.017B | 0.00 |
| KindlyMD (KDLY) | $0.017B | 0.00 | |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |